S

Scribe Therapeutics Inc
D

SCTX

17.870
USD
-1.42
(-7.36%)
مغلق
حجم التداول
0
الربح لكل سهم
-10
العائد الربحي
-
P/E
-10
حجم السوق
338,309,122

العنوان: Scribe Therapeutics Inc

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.